Theseus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.345; its P/E ratio is -3.02; Theseus Pharmaceuticals is scheduled to report earnings on March 7, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -13.50M	$ -14.80M	$ -14.59M	$ -13.55M	$ -15.95M
EBITDA	$ -15.22M	-	$ -15.38M	$ -13.97M	$ -15.93M
Net Income Common Stockholders	$ -13.50M	$ -29.61M	$ -29.17M	$ -27.27M	$ -14.74M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 205.12M	$ 208.21M	$ 236.63M	$ 197.98M	$ 212.43M
Total Assets	$ 234.63M	$ 245.07M	$ 255.21M	$ 222.45M	$ 230.29M
Total Debt	$ 3.66M	$ 3.77M	$ 3.88M	$ 3.98M	$ 4.12M
Net Debt	$ -201.47M	$ -204.44M	$ -232.76M	$ -194.00M	$ -208.31M
Total Liabilities	$ 10.11M	$ 10.99M	$ 10.13M	$ 14.83M	$ 11.70M
Stockholders Equity	$ 224.52M	$ 234.06M	$ 245.46M	$ 207.62M	$ 218.59M
Cash Flow	-
Free Cash Flow	$ -11.08M	-	$ -18.63M	$ -9.90M	$ -7.29M
Operating Cash Flow	$ -11.03M	-	$ -18.63M	$ -9.89M	$ -7.23M
Investing Cash Flow	$ 10.08M	-	$ -15.76M	$ -11.13M	$ -12.30M
Financing Cash Flow	-	-	$ 49.49M	$ 112.00K	$ 0.00

Currency in USD

Theseus Pharmaceuticals Earnings and Revenue History

Income Statement >

Theseus Pharmaceuticals Debt to Assets

Balance Sheet >

Theseus Pharmaceuticals Cash Flow

Cash Flow >

Theseus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing